Very early researchLooking for participantsNCT04744116
What this trial is testing
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmSteroid Refractory Graft Versus Host Disease
M.D. Anderson Cancer Center 24